LSN 2463359
CAS: 1401031-52-4
Ref. 3D-BGC03152
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Informação sobre produto
- 2-Pyridinecarboxamide, N-(1-methylethyl)-5-[2-(4-pyridinyl)ethynyl]-
- N-(1-Methylethyl)-5-[2-(4-pyridinyl)ethynyl]-2-pyridinecarboxamide
LSN 2463359 is a novel, potent, and selective allosteric modulator of the metabotropic glutamate receptor. It is currently in clinical development for the treatment of neurodevelopmental disorders such as attention deficit hyperactivity disorder (ADHD) and narcolepsy. LSN 2463359 has been shown to be safe and well tolerated in vivo studies in rats and mice. The drug improved ADHD-related symptoms in rodent models of ADHD. LSN 2463359 also reduced cataplexy episodes in narcoleptic patients who had been unresponsive to other treatments.
Propriedades químicas
Consulta técnica sobre: 3D-BGC03152 LSN 2463359
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
